Blue Horseshoe Stocks

Blue Horseshoe Stocks: Options, SGMO Recaps & More

Snap, Inc. SNAP – Options Recap

We called for a course-correct on SNAP in our premarket report on Friday after the stock had taken a post-earnings pounding the previous day. Our hunch was spot-on, as SNAP came roaring back to fill a portion of the gap that its beat-down had created, and regardless of which contracts had been chosen, there were sizable gains there for the taking..

We were looking at the SNAP Weekly $18 Calls for potential daytrades, as well as the SNAP 6/16 $18 & 19 Calls for a longer-term idea.

The Weekly $18’s ran from .25-1.38 for a 452% rip. The 6/16 $18’s made a 69% move from 1.18-2.00, while the 06/16 $19 Calls traded from .75-1.45; a 93% pop. We’ll continue to monitor those June 16th calls, and take rolling up to the $20-level into consideration as the stock is once again up in the premarket.
_____

We also added AZN $32-33.50 Weekly Calls as an extra idea on Friday morning and two out of the four contracts in that range provided traders with solid chances for multi-bag gains as well. The movement came in the $33 Calls which ran 112% from .40-.85, and the $33.50’s, which saw a 450% surge from .10-.55.

Sangamo Therapeutics, Inc. SGMO

We had initially tagged SGMO for observation in Thursday morning’s extended watchlist, and the stock finished out the week in strong fashion, recording higher highs and higher lows each day.

On the whole, we’ve thus far seen SGMO trade up from Thursday’s low of 6.05 to a high of 8.5385 on Friday. That works out to a two-day swing of 41%, which is actually quite impressive for a stock in the $6-8 range. We’ll continue to track SGMO in the event that the trend spills over into this week.

BravaTek Solutions, Inc. BVTK

BVTK is a top-notch super sub-penny runner that came out of our daily trader’s chatroom* a month ago and went from .0002-.0041 in a two-day span.

Following that epic run there were a few profitable dip-and-rip opportunities, and Friday we noticed the stock making another solid 100% intraday day run on increasing volume. We want to keep this one on watch this week for a possible continuation of momentum!

*Do you subscribe to our mailing list? If so, you’re eligible to participate and/or observe our daily trader’s chats via Skype. Simply send a contact request to username ‘stocksumo’ and we’ll take care of the rest.

Extended Watchlist:
OME, WLB, XTNT, CYRM, IDXG, SORL,

Blue Horseshoe Stocks: Huge VRX Calls, New Ideas & More

Valeant Pharmaceuticals, Inc. VRX

Our latest round of VRX Calls will almost certainly go down as one of our best three-day swings on any idea we’ve ever formulated. Beginning on Tuesday when we offered up the VRX Weekly $10.50-12 Calls as a target range. That day the stock traded as low as 10.57 before beginning this epic run that facilitated some truly impressive gains. VRX continued to bull its way to new highs yesterday, hitting 14.55, which in itself represents a 38% rise over Tuesday’s low.

Just like we did in yesterday’s premarket report, we’ve included the intraday moves, as well as our overall observed gains.

$10.50 Calls – Daily Range: 1.95-3.89 – Daily Gain: 118% – Total Range: .40-3.89 – 3-Day Swing: 873%
$11 Calls – Daily Range: 1.46-3.50 – Daily Gain: 140% – Total Range: .18-3.50 – 3-Day Swing: 1844%
$11.50 Calls – Daily Range: 1.27-2.99 – Daily Gain: 135% – Total Range: .08-2.99 – 3-Day Swing: 3638%
$12 Calls – Daily Range: .51-2.51 – Daily Gain: 392% – Total Range: .02-2.51 – 3-Day Swing: 12450%

A hearty congratulations goes out to anyone who took advantage of one of our best ideas of the year so far!

Northern Dynasty Minerals Ltd. NAK

Following our alerts on the stock in March at which time we stated that we believed there was “serious upside potential” for NAK, the stock has proven our assumption to be accurate. It has lived up to that potential as well in recent week, and this morning we’re seeing the stock gapping up to new highs in the premarket today with shares changing hands for as much as 2.60.

From the 1.06 low we observed in March, that represents a roughly two-month upswing of 145%

Today’s heightened activity likely stems from the new announcement the company made via PR this morning. Its wholly-owned subsidiary, Alaska-based Pebble Limited Partnership, and the US Environmental Protection Agency have reached a settlement agreement with respect to the parties’ longstanding legal dispute.

Under the terms of the settlement agreement, EPA has agreed the Pebble Project can proceed into normal course permitting under the Clean Water Act and National Environmental Policy Act. (>View Full PR)

Snap, Inc. SNAP – Options Ideas

SNAP took a pounding yesterday after releasing earnings that many are referring to as a disaster, but is recovering in the premarket today. We want to try to signal a range of calls to coincide with what could be a significant course-correct.

We’re looking at the SNAP Weekly $18 Calls* for quick daytrading opportunities, as well as the SNAP 6/16 $18-19 Calls for a longer-term recovery idea.

Bonus Idea: AZN $32-33.50 Weekly Calls*

*Never attempt to trade weekly options on a Friday unless you are a highly experienced trader- it’s an exceedingly risky proposition.

Extended Watchlist:
ANY, TCCO, FNJN, CLSN, URRE, PBR,

Blue Horseshoe Stocks: MNKD, VRX Recaps & More

MannKind Corp. MNKD

We tagged MNKD a week ago today in our premarket report on May 4th, and wanted to circle back around this morning to go over the excellent performance the stock has recorded since then. At the time the stock had been looking like it wanted to rebound after crashing down to a bottom and our decision to mention it turned out to be timed perfectly.

In each of the past five sessions MNKD has registered higher highs and higher lows, continuing to gain back ground that it had lost in previous weeks. From last Thursday’s low of .688, the stock has gone on to reach a high of 1.88, which represents an increase of 173% while volume over the same period has been impressive. The stock traded its highest volume since 2014 yesterday, so we’re really eager to continue tracking the activity in MNKD.

Valeant Pharmaceuticals, Inc. VRX

Despite already showing us amazing single-session gains ranging from 380-3600% on Tuesday, which we recapped in yesterday’s premarket report, our options idea for the VRX chain, the Weekly $10.50-12 Calls saw even further advances once the session kicked off.

We’ve included the total possible intraday gains from yesterday’s session, as well as the overall gains from our observed lows on Tuesday morning.

$10.50 Calls – Daily Range: 1.43-2.36 – Daily Gain: 65% – Total Range: .40-2.36 – Two-Day Swing: 490%
$11 Calls – Daily Range: .92-1.99 – Daily Gain: 116% – Total Range: .18-1.99 – Two-Day Swing: 1005%
$11.50 Calls – Daily Range: .53-1.42 – Daily Gain: 68% – Total Range: .08-1.42 – Two-Day Swing: 1675%
$12 Calls – Daily Range: .29-.99 – Daily Gain: 241% – Total Range: .02-.99 – Two-Day Swing: 4850%

Even though it’s not even close to our only percentage gainer in the thousands, this round of options calls with VRX is certainly going down as one of our most solid picks of the year so far. Even if someone had only bought shares in VRX stock itself, they could have been up just over 22% on this two-day swing.

Groupon, Inc. GRPN

We want to place GRPN on recovery watch after noticing the stock coming up off a double-bottom, with a gap on the chart to fill to the upside, as you can see on the included snapshot.

We like to monitor plays in this position, so we’ll put it on our radars in the days and weeks ahead. Given the look of this chart, we’d classify this as relatively low-risk, low-reward in comparison one of our average plays.

Extended Watchlist:
DEST, LPSN, MSLI, SGMO, SYN, SYMX

Blue Horseshoe Stocks: Stellar Options Calls & More

Valeant Pharmaceuticals, Inc. VRX – Options Recap

In yesterday morning’s premarket report, we noted that VRX had been coming off of recent annual lows, had a beat on earnings, and was up considerably in early trading.

Our exact words were “We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.” Things did play out similarly. We did indeed see considerable gains, and quite frankly, that’s an understatement.

As VRX itself traded from 10.57 to 12.43, our targeted options calls posted astronomical moves on the day, giving traders a chance to grab a piece of the following gains:

$10.50 Calls – Range: .40-.1.92 – Max Gain: 380%
$11 Calls – Range: .18-1.50 – Max Gain: 733%
$11.50 Calls – Range: .08-1.05 – Max Gain: 1212%
$12 Calls – Range: .02-.74 – Max Gain: 3600%

This wasn’t even the first percentage gain in the thousands that we’ve rooted out in the past week. The SPY Weekly $238-50-239.50 Calls that we highlighted in Friday morning’s premarket report yielded a 4600% gainer on that day. Both of these plays serve as perfect examples of why we don’t limit our daily reports to stocks alone.

Cleantech Solutions International, Inc. CLNT

We did have a very nice play on the stock side of things as well yesterday, after we tagged CLNT in our extended watchlist. It ended up making a solid early push from a low of 4.11, and ran as high as 6.99 inside the first hour of trading.

That was good for intraday gains of up to 70% which we feel is quite good for a stock in this price range. CLNT is pulling back in premarket, but we will remain interested in possible bounce activity in the event that it holds support above yesterday’s swing low.

Proteon Therapeutics, Inc. PRTO

There’s an interesting situation unfolding with PRTO that warrants placing the stock on watch today. Despite reporting Q1 losses of $6.5M, the stock is gapping up heavily on the strength of a concurrent announcement. It pertains to the fact that the company’s investigatory treatment, vonapanitase, has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA).

Whenever such FDA news hits wires the resultant activity on the chart is sure to be interesting, which is evidenced by the the fact that traders are ignoring the disappointing quarterly figures that coincided with this event. Thus we are eager to track PRTO as we head through midweek.

Extended Watchlist:
ASTI, BZUN, LBIO, AAXN, ARGS, MTBC, REXX

Blue Horseshoe Stocks: Bottom-Plays, Options & More

Celadon Group, Inc. CGI

We’ve been seeing a fair bit of bottom-bouncers running across our desks this week, and CGI is the latest to grab our attention. What we’ve got here is a very enticing chart with just about everything we look for in a potential bottom play.

The stock is beginning to come off of being massively oversold, has set higher lows and higher highs for each of the last three sessions, and has a sizable gap to fill to the upside. We also have a MACD that appears as if a bullish cross could be forthcoming, so we’ll definitely want to keep an eye on CGI this week.

____

Two other stocks on our bottom watchlist, California Resources Corp. and CRC Uni-Pixel, Inc. UNXL will remain there. We signaled these two just yesterday, and despite recording only marginal gains on the day, we still want to leave them a spot on our radar as well.

Valeant Pharmaceuticals, Inc. VRX – Options Idea

Speaking of bottom-bouncers, VRX recently rebounded off of new 52-week lows, and is hitting our scanners this morning. With a pleasing Q1 earnings call which included solid boosts in profits for the quarter as well as reinforced guidance for the remainder of the year, VRX is gapping up considerably in the premarket.

We want to formulate an options idea to coincide with the increased activity and expected price action in a stock in this position. We’ve seen this sort of pattern many times before, and if things play out similarly here, the VRX Weekly $10.50-12 Calls could be in line to see considerable gains.

Extended Watchlist:
AMRS, ARLZ, CLNT, MTBC, XXII, ORRV(News)